Hector: Kingpin of Iran’s Oil Empire

Hossein Shamkhani. (Iranian media)
Hossein Shamkhani. (Iranian media)
TT

Hector: Kingpin of Iran’s Oil Empire

Hossein Shamkhani. (Iranian media)
Hossein Shamkhani. (Iranian media)

Interviews carried out by Bloomberg shed light on the “global kingpin for Iranian oil”, known as “Hector”.

The kingpin is Hossein Shamkhani, the son of Ali Shamkhani, advisor to Supreme Leader Ali Khamenei. He has “raked in billions of dollars in sales from commodities originating out of Iran, Russia and elsewhere, according to more than a dozen people familiar with the matter,” reported Bloomberg.

“Few know Shamkhani’s real identity and he is widely known only as Hector, the people said.”

“Companies in his network also sell oil and petrochemicals from non-sanctioned nations and sometimes mix crude from various jurisdictions, so even buyers who test barrels may not be able to identify the country of origin, the people said,” added the report.

Shamkhani’s rise

His rise to power “offers a glimpse into parts of a sprawling shadow economy of dark oil fleets that have sprung up since Russia's February 2022 invasion of Ukraine. It also shows an increasing cooperation between Tehran and Moscow as global powers ratchet up sanctions against both governments,” said the report.

“Washington faces challenges clamping down on this trade because that risks pushing up prices at the pump in an election year. Meantime, Iran gets an annual windfall of some $35 billion from its oil exports, a boon as it backs proxy groups that have attacked Israeli or Western assets” and it appears that Shamkhani has been tasked with this mission.

Bloomberg said the US has imposed sancstions on ships believed to be operating within Shamkhani’s network, revealed people informed in the matter.

Shamkhani and parts of his trading network that do some business inside the dollar system, are under investigation for possible sanctions violations by the Federal Bureau of Investigation and the Treasury Department, according to the people and documents seen by Bloomberg.

Shamkhani denies everything

In an emailed response to questions, the director of his company said “the firm has no connection with Shamkhani while a lawyer representing the company said it follows all rules and has no links with any Russian or Iranian interests.” He denied owning any oil company, controlling a trading network or having a firm involved in commodities deals with Iran or Russia.

“Shamkhani’s influence is so wide that products supplied by entities in his network have also reached global majors like China’s Sinopec, US-based Chevron Corp. and UK-based BP Plc, according to people familiar with the matter,” continued Bloomberg.

“People familiar with Shamkhani’s empire said he effectively oversees an intertwined web of companies,” it added. “Business ownership, shareholding and control information are easy to obscure, and other executives have been formally registered as the owners and managers, the people said.”

“As one of Iran’s most profitable sectors, oil is top of mind for officials in the US. International restrictions on crude sales have put sharp pressure on the Iranian economy for years. Even so, the Iran helps fund Hezbollah, which has been trading rocket fire with Israel, as well as Houthi militants who have been attacking Western and Israeli ships in the Red Sea. It also backs the Palestinian group Hamas, which has been at war with Israel in Gaza for almost 11 months.”

Moscow and Beirut

“Over the last three decades, Shamkhani’s father Ali served as naval commander for the Islamic Revolutionary Guard Corps, defense minister and then Secretary of Iran’s Supreme National Security Council, the country’s top security body.”

“The younger Shamkhani is in his 40s and was born in Tehran, according to people who have worked with him. He attended university in Moscow and Beirut before returning to the Iranian capital to obtain a Master of Business Administration, an archived LinkedIn profile says. Shamkhani’s Russian connections are particularly valuable at a time when Tehran and Moscow, both under Western sanctions, are strengthening their military and economic cooperation,” reported Bloomberg.

“My father never had nor does he have anything to do with my business activities,” Shamkhani said.

During a brief TV appearance in 2008, the elder Shamkhani said he advised his son to go into the private sector rather than follow in his footsteps with a government post.



New Mpox Strain Is Changing Fast; African Scientists Are ‘Working Blind’ to Respond 

Dr. Robert Musole, medical director of the Kavumu hospital (R) consults an infant suffering from a severe form of mpox at the Kavumu hospital, 30 km north of Bukavu in eastern Democratic Republic of Congo, August 24, 2024. (AFP)
Dr. Robert Musole, medical director of the Kavumu hospital (R) consults an infant suffering from a severe form of mpox at the Kavumu hospital, 30 km north of Bukavu in eastern Democratic Republic of Congo, August 24, 2024. (AFP)
TT

New Mpox Strain Is Changing Fast; African Scientists Are ‘Working Blind’ to Respond 

Dr. Robert Musole, medical director of the Kavumu hospital (R) consults an infant suffering from a severe form of mpox at the Kavumu hospital, 30 km north of Bukavu in eastern Democratic Republic of Congo, August 24, 2024. (AFP)
Dr. Robert Musole, medical director of the Kavumu hospital (R) consults an infant suffering from a severe form of mpox at the Kavumu hospital, 30 km north of Bukavu in eastern Democratic Republic of Congo, August 24, 2024. (AFP)

Scientists studying the new mpox strain that has spread out of Democratic Republic of Congo say the virus is changing faster than expected, and often in areas where experts lack the funding and equipment to properly track it.

That means there are numerous unknowns about the virus itself, its severity and how it is transmitting, complicating the response, half a dozen scientists in Africa, Europe and the United States told Reuters.

Mpox, formerly known as monkeypox, has been a public health problem in parts of Africa since 1970, but received little global attention until it surged internationally in 2022, prompting the World Health Organization to declare a global health emergency. That declaration ended 10 months later.

A new strain of the virus, known as clade Ib, has the world's attention again after the WHO declared a new health emergency.

The strain is a mutated version of clade I, a form of mpox spread by contact with infected animals that has been endemic in Congo for decades. Mpox typically causes flu-like symptoms and pus-filled lesions and can kill.

Congo has had more than 18,000 suspected clade I and clade Ib mpox cases and 615 deaths this year, according to the WHO. There have also been 222 confirmed clade Ib cases in four African countries in the last month, plus a case each in Sweden and Thailand in people with a travel history in Africa.

"I worry that in Africa, we are working blindly," said Dr. Dimie Ogoina, an infectious diseases expert at Niger Delta University Hospital in Nigeria who chairs the WHO's mpox emergency committee. He first raised the alarm about potential sexual transmission of mpox in 2017, now an accepted route of spread for the virus.

"We don’t understand our outbreak very well, and if we don't understand our outbreak very well, we will have difficulty addressing the problem in terms of transmission dynamics, the severity of the disease, risk factors of the disease," Ogoina said. "And I worry about the fact that the virus seems to be mutating and producing new strains."

He said it took clade IIb in Nigeria five years or more to evolve enough for sustained spread among humans, sparking the 2022 global outbreak. Clade Ib has done the same thing in less than a year.

MUTATING 'MORE RAPIDLY'

Mpox is an orthopoxvirus, from the family that causes smallpox. Population-wide protection from a global smallpox vaccine campaign 50 years ago has waned, as the vaccinating stopped when the disease was eradicated.

Genetic sequencing of clade Ib infections, which the WHO estimates emerged mid-September 2023, show they carry a mutation known as APOBEC3, a signature of adaptation in humans.

The virus that causes mpox has typically been fairly stable and slow to mutate, but APOBEC-driven mutations can accelerate viral evolution, said Dr. Miguel Paredes, who is studying the evolution of mpox and other viruses at Fred Hutchison Cancer Center in Seattle.

"All the human-to-human cases of mpox have this APOBEC signature of mutations, which means that it's mutating a little bit more rapidly than we would expect," he said.

Paredes and other scientists said a response was complicated by several mpox outbreaks happening at once.

In the past, mpox was predominantly acquired through human contact with infected animals. That is still driving a rise in Congo in clade I cases – also known as clade Ia - likely due in part to deforestation and increased consumption of bushmeat, scientists said.

The mutated versions, clade Ib and IIb, can now essentially be considered a sexually transmitted disease, said Dr. Salim Abdool Karim, a South African epidemiologist and chair of the Africa CDC’s mpox advisory committee. Most of the mutated clade Ib cases are among adults, driven at first by an epidemic among female sex workers in South Kivu, Congo.

The virus also can spread through close contact with an infected person, which is likely how clusters of children have been infected with clade Ib, particularly in Burundi and in eastern Congo’s displacement camps, where crowded living conditions may be contributing.

Children, pregnant women and people with weakened immune systems or other illnesses may be at greater risk of serious mpox disease and death, say the WHO and mpox scientists.

Clade I has typically caused more severe disease, with fatality rates of 4%-11%, compared to around 1% for clade II. Ogoina said data from Congo suggests few have died of the new Ib version, but he feared some data is being mixed up.

More research is urgently needed, but three teams tracking mpox outbreaks in Africa say they cannot even access chemicals needed for diagnostic tests. Clade Ib can also be missed by some diagnostic tests.

Planning a response, including vaccination strategies, without this is difficult, the scientists said.

Karim said around half of cases in eastern Congo, where Ib is particularly prevalent, are only being diagnosed by doctors, with no laboratory confirmation.

Getting samples to labs is difficult because the healthcare system is already under pressure, he said. And around 750,000 people have been displaced amid fighting between the M23 rebel group and the government.

Many African laboratories cannot get the supplies they need, said Dr. Emmanuel Nakoune, an mpox expert at the Institut Pasteur in Bangui, Central African Republic, which also has clade Ia cases.

"This is not a luxury," he said, but necessary to track deadly outbreaks.